295 related articles for article (PubMed ID: 14614020)
1. Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.
Junttila TT; Laato M; Vahlberg T; Söderström KO; Visakorpi T; Isola J; Elenius K
Clin Cancer Res; 2003 Nov; 9(14):5346-57. PubMed ID: 14614020
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of ERBB receptors and ligands in human transitional cell carcinoma of the bladder.
Amsellem-Ouazana D; Bièche I; Tozlu S; Botto H; Debré B; Lidereau R
J Urol; 2006 Mar; 175(3 Pt 1):1127-32. PubMed ID: 16469638
[TBL] [Abstract][Full Text] [Related]
3. Is quantitative real-time RT-PCR an adjunct to immunohistochemistry for the evaluation of ErbB2 status in transitional carcinoma of the bladder?
Amsellem-Ouazana D; Bièche I; Molinié V; Elie C; Vieillefond A; Tozlu S; Botto H; Debré B; Lidereau R
Eur Urol; 2006 Jun; 49(6):1035-42; discussion 1042-3. PubMed ID: 16466848
[TBL] [Abstract][Full Text] [Related]
4. Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain.
Thompson M; Lauderdale S; Webster MJ; Chong VZ; McClintock B; Saunders R; Weickert CS
Brain Res; 2007 Mar; 1139():95-109. PubMed ID: 17280647
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas.
Andersson U; Guo D; Malmer B; Bergenheim AT; Brännström T; Hedman H; Henriksson R
Acta Neuropathol; 2004 Aug; 108(2):135-42. PubMed ID: 15148612
[TBL] [Abstract][Full Text] [Related]
6. Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder.
Chow NH; Chan SH; Tzai TS; Ho CL; Liu HS
Clin Cancer Res; 2001 Jul; 7(7):1957-62. PubMed ID: 11448910
[TBL] [Abstract][Full Text] [Related]
7. ErbB receptor tyrosine kinase family expression levels in urothelial bladder carcinoma.
Gunes S; Sullu Y; Yegin Z; Buyukalpelli R; Tomak L; Bagci H
Pathol Res Pract; 2013 Feb; 209(2):99-104. PubMed ID: 23333248
[TBL] [Abstract][Full Text] [Related]
8. Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells.
Junttila TT; Sundvall M; Lundin M; Lundin J; Tanner M; Härkönen P; Joensuu H; Isola J; Elenius K
Cancer Res; 2005 Feb; 65(4):1384-93. PubMed ID: 15735025
[TBL] [Abstract][Full Text] [Related]
9. Expression of the type 1 tyrosine kinase growth factor receptors EGF receptor, c-erbB2 and c-erbB3 in bladder cancer.
Rajkumar T; Stamp GW; Pandha HS; Waxman J; Gullick WJ
J Pathol; 1996 Aug; 179(4):381-5. PubMed ID: 8869284
[TBL] [Abstract][Full Text] [Related]
10. Expression, localization, and regulation of the neuregulin receptor ErbB3 in mouse heart.
Campreciós G; Lorita J; Pardina E; Peinado-Onsurbe J; Soley M; Ramírez I
J Cell Physiol; 2011 Feb; 226(2):450-5. PubMed ID: 20672328
[TBL] [Abstract][Full Text] [Related]
11. Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.
Li Z; Mei Y; Liu X; Zhou M
Cell Signal; 2007 Mar; 19(3):466-71. PubMed ID: 16978839
[TBL] [Abstract][Full Text] [Related]
12. Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells.
Zheng Y; Izumi K; Yao JL; Miyamoto H
Endocr Relat Cancer; 2011 Aug; 18(4):451-64. PubMed ID: 21613411
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer.
Ariazi EA; Clark GM; Mertz JE
Cancer Res; 2002 Nov; 62(22):6510-8. PubMed ID: 12438245
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of ERBB family mRNA expression in breast carcinomas.
Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R
Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037
[TBL] [Abstract][Full Text] [Related]
15. ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease.
Gilbertson RJ; Bentley L; Hernan R; Junttila TT; Frank AJ; Haapasalo H; Connelly M; Wetmore C; Curran T; Elenius K; Ellison DW
Clin Cancer Res; 2002 Oct; 8(10):3054-64. PubMed ID: 12374672
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of vascular endothelial growth factor165b in transitional cell carcinoma of the bladder.
Das K; Zhao Y; Sugiono M; Lau W; Tan PH; Cheng C
Urol Oncol; 2007; 25(4):317-21. PubMed ID: 17628298
[TBL] [Abstract][Full Text] [Related]
17. Association of ErbB1-4 expression in invasive breast cancer with clinicopathological characteristics and prognosis.
Fujiwara S; Ibusuki M; Yamamoto S; Yamamoto Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):472-81. PubMed ID: 23100016
[TBL] [Abstract][Full Text] [Related]
18. HER-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder.
Coogan CL; Estrada CR; Kapur S; Bloom KJ
Urology; 2004 Apr; 63(4):786-90. PubMed ID: 15072912
[TBL] [Abstract][Full Text] [Related]
19. Neuregulin expression, function, and signaling in human ovarian cancer cells.
Gilmour LM; Macleod KG; McCaig A; Sewell JM; Gullick WJ; Smyth JF; Langdon SP
Clin Cancer Res; 2002 Dec; 8(12):3933-42. PubMed ID: 12473609
[TBL] [Abstract][Full Text] [Related]
20. c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer.
Knowlden JM; Gee JM; Seery LT; Farrow L; Gullick WJ; Ellis IO; Blamey RW; Robertson JF; Nicholson RI
Oncogene; 1998 Oct; 17(15):1949-57. PubMed ID: 9788438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]